Abstract
Objective
To evaluate the effectiveness of platelet-rich fibrin (PRF) in the repair of cleft palate (CP), with a primary goal of reducing the occurrence of postoperative palatal fistula formation.
Design
An RCT was conducted with a 1:1 allocation ratio.
Setting
Single-center study conducted in the Department of Plastic & Reconstructive Surgery at a tertiary care center.
Participants
100 CP repair patients enrolled based on the following inclusion criteria:
Non-syndromic CP Age between 1 and 3 years Informed consent.
Interventions
Participants were randomized using a computer-generated sequence into 2 groups (n = 50 each). The intervention group received PRF, prepared by Choukroun's method from a 5 to 7 mL blood sample, and applied during surgery. The control group underwent standard CP repair without PRF. Both groups received identical pre & postoperative care.
Main Outcomes
Palatal-fistula formation, wound dehiscence, and postoperative bleeding were assessed.
No cases of wound dehiscence or postoperative bleeding were observed in either group.
Palatal fistula occurred in 3 patients (6%) in the control group (non-PRF), while no cases were observed in the PRF group.
Results
Three palatal fistula cases were observed (3%; n = 100), 0% in the PRF group (n = 50), and 6% in the non-PRF group (n = 50).
Conclusions
While PRF appears to be safe, biologically promising, and cost-effective adjunct in CP repair; the study was inconclusive as the small number of fistula occurrence limited ability to statistically substantiate its efficacy in reducing palatal fistula.
Get full access to this article
View all access options for this article.